Good Laboratory Practice (GLP)

ProPharma ensures global GLP and lab compliance with QMS development, inspection readiness, remediation, and quality oversight.

GLP Consulting Services

ProPharma's Quality & Compliance team offers Sponsors, laboratories, and CROs a full range of global good laboratory practice and compliance support services for Clinical Study, Pharmacy, CMO, CDMO, CROs, and third-party testing labs. We assist in achieving and maintaining full compliance with GLP, GCLP, OECD, CAP, and CLIA regulations. Our consultants combine deep regulatory knowledge, operational experience, and a global perspective to ensure your non-clinical, clinical development, and bio/analytical programs meet international standards to support compliance aspects such as:

smiling-woman-high-fiving-coworker-as-983431523-650x425

Illustration of ProPharma's Good Laboratory Practice (GLP) services overview

 

Gloved hand working with test tubes and vials in a lab

Nonclinical GLP Laboratory  Compliance Services

We offer comprehensive Good Laboratory Practice support for facilities, sponsors, and testing labs conducting regulated nonclinical safety and toxicology studies.

Our GLP services include:

  • GLP Facility & Study Conduct Audits
  • Bioanalytical and Histopathology Compliance Assessments
  • Test Article and Specimen Handling Reviews
  • Toxicology Study Design and In-Life Phase Oversight (In-Vivo / In-Vitro)
  • Data Integrity Audits (21 CFR Part 11, OECD, ALCOA+)
  • Regulatory Inspection Readiness (FDA, EMA, MHRA, PMDA)

Enabling IND/CTA/NDA Laboratory & Testing Compliance

We support the transition from discovery through Investigational New Drug (IND) and Clinical Trial Application (CTA) to New Drug Application (NDA) testing with compliance audits, quality management system support, data integrity monitoring, and QA oversight services.

Our services include:

  • GLP Oversight of IND/CTA-Supporting Studies
  • CRO and Laboratory Qualification Audits
  • Electronic Lab System Assessments (LIMS, ELN, CDS)
  • Sponsor Oversight SOPs and GLP Quality Systems
  • Regulatory Submission Readiness (IND, CTA)
Woman focused on injecting test tube

GCLP, CAP & CLIA Compliance for Clinical Trial Laboratory

Ensure your clinical trial testing laboratories meet GCLP, CLIA, and CAP requirements to support compliant and inspection-ready operations.

GCLP Compliance Services

For central labs, specialty labs, and sponsor-oversight programs: 

  • GCLP Audits and Mock Inspections
  • SOP Development for Sample Handling and Bioanalytical Testing
  • Chain of Custody and Logistics Reviews
  • Laboratory Vendor Qualification and Monitoring

CAP/CLIA Compliance Services (U.S. Labs)

For clinical labs performing testing under U.S. regulations: 

  • CLIA Certification Consulting and Gap Assessments
  • CAP Accreditation Preparation and Inspection Readiness
  • QMS Implementation and Lab Process Optimization
  • Response Planning for CAP/CLIA Deficiencies
  • Audit and Validation of Laboratory Information Systems (LIS)

Clinical and CMC Transition Support

We support clinical development teams as they interface with data from nonclinical and early CMC programs.

Services include:

  • GLP-to-GCP Data Traceability Audits
  • Oversight of Bioanalytical Labs Supporting Clinical Trials
  • Companion Diagnostic and Biomarker Lab Compliance Reviews
  • Technical Transfer
    and Method Transfer Compliance Reviews
  • GCLP/CMC Consulting for Clinical Sample Analysis

Analytical Testing Compliance for Sponsors

We help commercial and manufacturing organizations manage GLP-related functions within GxP environments.

Services include: 

  • Non-GMP Laboratory Phase Appropriate Best Scientific Practices Compliance
  • GLP Audit of R&D Labs within GMP Sites
  • Analytical Method Transfer Compliance Support
  • Stability and Shelf-Life Study Review

General Laboratory Compliance Services

Whether you're preparing for an inspection or establishing your first QA system, our global consultants can help.

  • Global Regulatory Intelligence (FDA, EMA, MHRA, OECD, WHO)
  • SOP Development & GLP/GCLP Policy Creation
  • Staff Training (GLP, GCLP, CAP, CLIA, Data Integrity)
  • CAPA Planning
    and Remediation Project Management
  • Mock Inspections and Enforcement Readiness Support
  • Quality System Development and Staff Augmentation

Partner with ProPharma for Good Laboratory Practice Services

Partner with us for expert laboratory compliance and quality solutions. Contact ProPharma today to learn how we can support your organization's laboratory Quality Assurance needs.

News & Insights

From Defensible to Predictive: How High-Functioning MLR Teams Are Evolving Their Risk Assessment Approach

October 21, 2026

From Defensible to Predictive: How High-Functioning MLR Teams Are Evolving Their...

Recent FDA enforcement activity is changing how MLR teams assess promotional risk. Learn why organizations are moving from defensible claims to predictive, enforcement-informed risk assessment.

AI-Readiness 101: AI Success Starts with Understanding Your Data

October 19, 2026

AI-Readiness 101: AI Success Starts with Understanding Your Data

Unlock AI success by understanding your data. Learn the foundations of AI readiness and how to build trust in your data for reliable insights.

What It Takes to Build a Successful Global Medical Information Program in Veterinary Medicine

October 13, 2026

What It Takes to Build a Successful Global Medical Information Program in Veteri...

Learn how to build a successful global medical information program in veterinary medicine, navigating complexity and enhancing customer support across diverse markets.

ProPharma Advances Technology Enablement Strategy with AI-Assisted Capability for ANDA Submission Development

July 8, 2026

ProPharma Advances Technology Enablement Strategy with AI-Assisted Capability fo...

ProPharma unveils an AI-assisted capability to enhance ANDA submission development, improving efficiency and maintaining regulatory excellence for clients.

ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and HTA Capabilities

June 18, 2026

ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and H...

ProPharma welcomes Kevin van Dooren as Vice President, HEOR and Market Access, strengthening integrated EU regulatory, HTA, reimbursement, and market access capabilities for life sciences companies.

ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero Targets

January 27, 2026

ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero T...

ProPharma’s greenhouse gas reduction targets are validated by SBTi, aligning with the Net-Zero Standard and a commitment to reach net-zero by 2050.

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Case Study Accelerating Clinical Trial Activation Across Latin America - ProPharma

October 20, 2026

Accelerating Clinical Trial Activation Across Latin America

Launching clinical trials across multiple countries requires navigating varying regulatory requirements, site contracts, translations, import/export processes, and site engagement activities, all...

Infographic Flexible Resourcing Without Limits: Scaling Capabilities Across the Development Lifecycle - ProPharma

September 18, 2026

Flexible Resourcing Without Limits: Scaling Capabilities Across the Development ...

Development complexity doesn’t increase in a straight line. As programs progress from discovery through Phase III, submission, and post-approval, demands for medical writing, biometrics, clinical...

Case Study Achieving Continuous Audit Readiness Across a Global Medical Information Program - ProPharma

August 3, 2026

Achieving Continuous Audit Readiness Across a Global Medical Information Program

Maintaining continuous audit readiness across a global Medical Information operation requires more than periodic audit preparation. Organizations operating across multiple countries and affiliates...

Beyond the Buzz: Leveraging Community Management to Enhance Medical Information

December 2, 2026

Beyond the Buzz: Leveraging Community Management to Enhance Medical Information

Patients, caregivers, and healthcare professionals are increasingly turning to digital channels to seek information, share experiences, and discuss treatments. Join this webinar to explore how...

Empowering Sites, Engaging Patients: Strategies to Improve Clinical Trial Performance 

November 12, 2026

Empowering Sites, Engaging Patients: Strategies to Improve Clinical Trial Performance 

Sites are being asked to do more than ever before while balancing increasing trial complexity, patient expectations, and operational demands. Join this webinar to explore how flexible, integrated...

Reg Reels: Your Snapshot of the Latest Pharmacovigilance Regulatory Developments

October 22, 2026

Reg Reels: Your Snapshot of the Latest Pharmacovigilance Regulatory Developments

Tired of working through lengthy regulatory documents? Join Reg Reels for a concise, video-led look at the latest pharmacovigilance developments from the EMA, FDA, and MHRA. Our experts will...

News & Insights

From Defensible to Predictive: How High-Functioning MLR Teams Are Evolving Their Risk Assessment Approach

October 21, 2026

From Defensible to Predictive: How High-Functioning MLR Teams Are Evolving Their...

Recent FDA enforcement activity is changing how MLR teams assess promotional risk. Learn why organizations are moving from defensible claims to predictive, enforcement-informed risk assessment.

AI-Readiness 101: AI Success Starts with Understanding Your Data

October 19, 2026

AI-Readiness 101: AI Success Starts with Understanding Your Data

Unlock AI success by understanding your data. Learn the foundations of AI readiness and how to build trust in your data for reliable insights.

What It Takes to Build a Successful Global Medical Information Program in Veterinary Medicine

October 13, 2026

What It Takes to Build a Successful Global Medical Information Program in Veteri...

Learn how to build a successful global medical information program in veterinary medicine, navigating complexity and enhancing customer support across diverse markets.

Previous Post Arrow Next Post Arrow
ProPharma Advances Technology Enablement Strategy with AI-Assisted Capability for ANDA Submission Development

July 8, 2026

ProPharma Advances Technology Enablement Strategy with AI-Assisted Capability fo...

ProPharma unveils an AI-assisted capability to enhance ANDA submission development, improving efficiency and maintaining regulatory excellence for clients.

ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and HTA Capabilities

June 18, 2026

ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and H...

ProPharma welcomes Kevin van Dooren as Vice President, HEOR and Market Access, strengthening integrated EU regulatory, HTA, reimbursement, and market access capabilities for life sciences companies.

ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero Targets

January 27, 2026

ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero T...

ProPharma’s greenhouse gas reduction targets are validated by SBTi, aligning with the Net-Zero Standard and a commitment to reach net-zero by 2050.

Previous Post Arrow Next Post Arrow
ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Previous Award Arrow Next Award Arrow
Case Study Accelerating Clinical Trial Activation Across Latin America - ProPharma

October 20, 2026

Accelerating Clinical Trial Activation Across Latin America

Launching clinical trials across multiple countries requires navigating varying regulatory requirements, site contracts, translations, import/export processes, and site engagement activities, all...

Infographic Flexible Resourcing Without Limits: Scaling Capabilities Across the Development Lifecycle - ProPharma

September 18, 2026

Flexible Resourcing Without Limits: Scaling Capabilities Across the Development ...

Development complexity doesn’t increase in a straight line. As programs progress from discovery through Phase III, submission, and post-approval, demands for medical writing, biometrics, clinical...

Case Study Achieving Continuous Audit Readiness Across a Global Medical Information Program - ProPharma

August 3, 2026

Achieving Continuous Audit Readiness Across a Global Medical Information Program

Maintaining continuous audit readiness across a global Medical Information operation requires more than periodic audit preparation. Organizations operating across multiple countries and affiliates...

Previous Resource Arrow Next Resource Arrow
Beyond the Buzz: Leveraging Community Management to Enhance Medical Information

December 2, 2026

Beyond the Buzz: Leveraging Community Management to Enhance Medical Information

Patients, caregivers, and healthcare professionals are increasingly turning to digital channels to seek information, share experiences, and discuss treatments. Join this webinar to explore how...

Empowering Sites, Engaging Patients: Strategies to Improve Clinical Trial Performance 

November 12, 2026

Empowering Sites, Engaging Patients: Strategies to Improve Clinical Trial Performance 

Sites are being asked to do more than ever before while balancing increasing trial complexity, patient expectations, and operational demands. Join this webinar to explore how flexible, integrated...

Reg Reels: Your Snapshot of the Latest Pharmacovigilance Regulatory Developments

October 22, 2026

Reg Reels: Your Snapshot of the Latest Pharmacovigilance Regulatory Developments

Tired of working through lengthy regulatory documents? Join Reg Reels for a concise, video-led look at the latest pharmacovigilance developments from the EMA, FDA, and MHRA. Our experts will...

Previous Webinar Arrow Next Webinar Arrow